Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Little Green Pharma Ltd

Healthcare AU LGP

0.11AUD
0.01(10.00%)

Last update at 2026-03-11T00:11:00Z

Day Range

0.100.12
LowHigh

52 Week Range

0.100.14
LowHigh

Fundamentals

  • Previous Close 0.10
  • Market Cap33.64M
  • Volume34953
  • P/E Ratio5.50
  • Dividend Yield-%
  • EBITDA2.64M
  • Revenue TTM38.49M
  • Revenue Per Share TTM0.13
  • Gross Profit TTM 27.57M
  • Diluted EPS TTM0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -4.79200M -8.15256M -8.55665M -18.05176M 24.60M
Minority interest - - - - -
Net income 3.32M -8.15256M -9.20543M -18.28625M -4.35647M
Selling general administrative 14.90M 15.96M 4.66M 19.25M 3.52M
Selling and marketing expenses 7.53M - 3.51M - 2.11M
Gross profit 25.26M 13.63M 11.98M 3.38M 5.78M
Reconciled depreciation 3.72M 3.08M 2.98M - 0.69M
Ebit -4.40800M - -7.62781M -22.36922M 24.70M
Ebitda -0.68400M - -4.64332M - 25.38M
Depreciation and amortization 3.72M - 2.98M - 0.69M
Non operating income net other - - - - -
Operating income -4.04900M -9.16399M -7.62781M -18.96087M 24.70M
Other operating expenses 40.37M - 32.98M - 11.90M
Interest expense 0.38M 0.60M 0.93M - 0.09M
Tax provision -8.11600M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.32M -0.45785M 1.44M 1.52M 0.04M
Net interest income -0.36700M -0.46441M -0.87992M - -0.05226M
Extraordinary items - 0.00000M -0.64878M -0.23449M 0.00000M
Non recurring - - - - -
Other items - - - - -
Income tax expense -8.11600M - 4.32M - 28.96M
Total revenue 36.82M 25.63M 19.57M 10.53M 7.00M
Total operating expenses 25.16M 34.80M 25.39M - 10.67M
Cost of revenue 11.56M 12.00M 7.59M 7.15M 1.23M
Total other income expense net -1.24200M 1.48M 2.75M - -0.09154M
Discontinued operations - - - -0.31265M -0.23449M
Net income from continuing ops 3.32M -8.15256M -8.55665M - 24.60M
Net income applicable to common shares 3.32M -8.15256M -9.20543M -24.38166M 24.60M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 96.12M 86.29M 98.62M 95.95M 110.99M
Intangible assets 3.36M 3.46M 3.64M 0.67M 0.71M
Earning assets - - - - -
Other current assets 1.88M 1.59M 1.49M 1.00M 1.99M
Total liab 11.11M 9.03M 16.39M 20.47M 17.10M
Total stockholder equity 85.02M 77.26M 82.23M 75.48M 93.89M
Deferred long term liab - - 3.02M - -
Other current liab 0.99M - 0.06M 0.24M 3.27M
Common stock - - 101.18M 90.25M 86.20M
Capital stock 102.23M 101.93M 101.18M - 86.20M
Retained earnings -28.91400M -32.23725M -24.08469M -14.87926M 5.80M
Other liab - - - 0.02M -
Good will 0.86M - - - -
Other assets - - 3.41M 0.20M 0.83M
Cash 2.38M 4.97M 12.40M - 40.27M
Cash and equivalents - - 12.40M 20.09M 40.27M
Total current liabilities 8.74M 6.42M 11.04M 16.55M 15.89M
Current deferred revenue - - 1.07M - 11.37M
Net debt 0.71M - -0.53234M - -38.84869M
Short term debt - - 6.56M 11.88M 0.20M
Short long term debt 2.30M 2.36M 6.46M - -
Short long term debt total - - 11.87M - 1.42M
Other stockholder equity - - - 0.10M 1.90M
Property plant equipment - - 63.41M 59.58M 55.41M
Total current assets 22.71M 21.47M 31.15M 35.45M 54.03M
Long term investments 0.04M 0.36M 0.43M - 0.83M
Net tangible assets - - 81.61M 74.80M 93.17M
Short term investments - - - - -
Net receivables 3.64M 2.63M 7.38M 5.60M 3.66M
Long term debt 0.78M 1.14M 5.28M 3.78M 0.00000M
Inventory 13.83M 10.93M 8.91M 8.19M 7.25M
Accounts payable 3.93M 1.65M 3.36M 1.55M 1.04M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - 5.13M - 1.90M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 73.41M 64.82M 67.47M - 56.96M
Capital lease obligations 1.58M 1.65M 0.12M - 1.42M
Long term debt total - - 5.31M 3.90M 1.22M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -1.13500M -2.80414M -14.03105M - -12.73438M
Change to liabilities - - - -0.62083M -0.34687M
Total cashflows from investing activities -1.13500M -2.80414M -14.03105M -10.21384M -12.73438M
Net borrowings -0.41100M -4.68326M - 4.90M -0.24582M
Total cash from financing activities -0.53000M -4.72056M 13.03M 6.30M 53.87M
Change to operating activities - - - 0.81M -0.20342M
Net income -4.79200M -8.15256M -9.20543M -24.38166M 24.60M
Change in cash -2.59800M -7.45790M -7.68619M -26.91021M 36.00M
Begin period cash flow 4.97M 12.40M 20.09M 40.27M 4.27M
End period cash flow 2.38M 4.97M 12.40M 20.09M 40.27M
Total cash from operating activities -0.91700M 0.07M -6.94017M -22.89095M -5.14958M
Issuance of capital stock - 0.06M 10.11M - 56.35M
Depreciation 3.72M 3.08M 2.98M 1.31M 0.69M
Other cashflows from investing activities -0.89800M -1.36007M -9.10240M -0.25000M -0.50000M
Dividends paid - - 5.81M - 1.02M
Change to inventory -3.16000M - - 0.93M -3.84356M
Change to account receivables -0.04600M - - -2.32019M -2.41601M
Sale purchase of stock - 0.06M -0.83774M 1.05M -2.23820M
Other cashflows from financing activities -0.11900M 0.00000M 11.54M -1.11910M 1.79M
Change to netincome - - - 1.34M -23.62854M
Capital expenditures 0.24M 1.44M 4.93M 10.17M 1.06M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -3.44300M 1.70M -2.01190M -0.89482M -6.80987M
Stock based compensation - - - - -
Other non cash items 2.53M - - - -25.28882M
Free cash flow -1.15400M -1.37728M -11.86882M - -6.21103M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
LGP
Little Green Pharma Ltd		 0.01 10.00% 0.11 5.50 43.29 0.87 0.39 0.94 18.70
AFP
Aft Pharmaceuticals Ltd		 - -% 3.00 23.85 19.88 1.40 3.89 1.68 13.38
VLS
Vita Life Sciences Ltd		 -0.06 2.35% 2.49 14.06 42.73 1.51 2.56 1.19 7.04
SNT
Syntara Ltd		 0.001 3.33% 0.03 - 22.83 6.97 4.78 6.13 -2.1607
MVP
Medical Developments International Ltd		 0.005 1.25% 0.41 - 166.67 1.19 0.88 0.82 12.54

Reports Covered

Stock Research & News

View All

Profile

Little Green Pharma Ltd engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally. The company offers dried cannabis flower medicines and cannabis oils. Little Green Pharma Ltd was incorporated in 2016 and is based in West Perth, Australia.

Little Green Pharma Ltd

PO Box 690, West Perth, WA, Australia, 6872

Key Executives

Name Title Year Born
Ms. Fleta Jennifer Solomon CEO & Director NA
Mr. Angus McDougall Caithness Exec. Director NA
Mr. Paul Long Chief Operating Officer NA
Mr. Alistair Warren B.A., L.L.B. Gen. Counsel & Company Sec. NA
Ms. Celia Young Head of Marketing NA
Ms. Gabriela Franz Head of Sales & Distribution EU NA
Dr. Leon Warne Head of Research & Innovation NA
Ms. Lina Sandberg Head of Quality NA
Ms. Melanie Pugliese Head of Engagment NA
Brian Westergaard Head of IT NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.